Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous ibuprofen versus intravenous paracetamol for patent ductus arteriosus closure in preterm infants
IRCT20120215009014N321Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of ibuprofen and acetaminophen in patent ductus arteriosus (PDA) (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Patent ductus arteriosus occlusion. Started Nov 2019; status: completed.
02
Drugs
ibuprofenacetaminophen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on IRCT20120215009014N321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N321.